| Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer L Buscail, B Bournet, P Cordelier Nature Reviews Gastroenterology & Hepatology 17 (3), 153-168, 2020 | 504 | 2020 |
| Adult stromal cells derived from human adipose tissue provoke pancreatic cancer cell death both in vitro and in vivo B Cousin, E Ravet, S Poglio, F De Toni, M Bertuzzi, H Lulka, I Touil, ... PloS one 4 (7), e6278, 2009 | 304 | 2009 |
| MicroRNA-21 is induced early in pancreatic ductal adenocarcinoma precursor lesions MC Du Rieu, J Torrisani, J Selves, T Al Saati, A Souque, M Dufresne, ... Clinical chemistry 56 (4), 603-612, 2010 | 270 | 2010 |
| Targeting miR-21 for the therapy of pancreatic cancer F Sicard, M Gayral, H Lulka, L Buscail, P Cordelier Molecular Therapy 21 (5), 986-994, 2013 | 264 | 2013 |
| Pharmacological targeting of the protein synthesis mTOR/4E‐BP1 pathway in cancer‐associated fibroblasts abrogates pancreatic tumour chemoresistance C Duluc, S Moatassim‐Billah, M Chalabi‐Dchar, A Perraud, R Samain, ... EMBO molecular medicine 7 (6), 735-753, 2015 | 209 | 2015 |
| DNA methylation and cancer diagnosis Y Delpu, P Cordelier, WC Cho, J Torrisani International journal of molecular sciences 14 (7), 15029-15058, 2013 | 200 | 2013 |
| let-7 MicroRNA Transfer in Pancreatic Cancer-Derived Cells Inhibits In Vitro Cell Proliferation but Fails to Alter Tumor Progression J Torrisani, B Bournet, MC Du Rieu, M Bouisson, A Souque, J Escourrou, ... Human gene therapy 20 (8), 831-844, 2009 | 199 | 2009 |
| Targeting KRAS for diagnosis, prognosis, and treatment of pancreatic cancer: Hopes and realities B Bournet, C Buscail, F Muscari, P Cordelier, L Buscail European journal of cancer 54, 75-83, 2016 | 198 | 2016 |
| The silencing of microRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis N Hanoun, Y Delpu, AA Suriawinata, B Bournet, C Bureau, J Selves, ... Clinical chemistry 56 (7), 1107-1118, 2010 | 194 | 2010 |
| KRAS G12D Mutation Subtype Is A Prognostic Factor for Advanced Pancreatic Adenocarcinoma B Bournet, F Muscari, C Buscail, E Assenat, M Barthet, P Hammel, ... Clinical and translational gastroenterology 7 (3), e157, 2016 | 187 | 2016 |
| Characterization of the antiproliferative signal mediated by the somatostatin receptor subtype sst5 P Cordelier, JP Estève, C Bousquet, N Delesque, AM O’Carroll, ... Proceedings of the National Academy of Sciences 94 (17), 9343-9348, 1997 | 179 | 1997 |
| Signal transduction of somatostatin receptors negatively controlling cell proliferation G Ferjoux, C Bousquet, P Cordelier, N Benali, F Lopez, P Rochaix, ... Journal of Physiology-Paris 94 (3-4), 205-210, 2000 | 177 | 2000 |
| Genetic and epigenetic alterations in pancreatic carcinogenesis Y Delpu, N Hanoun, H Lulka, F Sicard, J Selves, L Buscail, J Torrisani, ... Current genomics 12 (1), 15, 2011 | 171 | 2011 |
| Multicellular tumor spheroid model to evaluate spatio-temporal dynamics effect of chemotherapeutics: application to the gemcitabine/CHK1 inhibitor combination in pancreatic cancer I Dufau, C Frongia, F Sicard, L Dedieu, P Cordelier, F Ausseil, ... BMC cancer 12, 1-11, 2012 | 153 | 2012 |
| Sporadic early-onset colorectal cancer is a specific sub-type of cancer: a morphological, molecular and genetics study S Kirzin, L Marisa, R Guimbaud, A De Reynies, M Legrain, P Laurent-Puig, ... PloS one 9 (8), e103159, 2014 | 150 | 2014 |
| Inhibition of growth and metastatic progression of pancreatic carcinoma in hamster after somatostatin receptor subtype 2 (sst2) gene expression and administration of cytotoxic … N Benali, P Cordelier, D Calise, P Pagès, P Rochaix, A Nagy, JP Estève, ... Proceedings of the National Academy of Sciences 97 (16), 9180-9185, 2000 | 149 | 2000 |
| Circulating miR-155, miR-145 and let-7c as diagnostic biomarkers of the coronary artery disease J Faccini, JB Ruidavets, P Cordelier, F Martins, JJ Maoret, V Bongard, ... Scientific reports 7 (1), 42916, 2017 | 139 | 2017 |
| Salivary microRNA in pancreatic cancer patients M Humeau, A Vignolle-Vidoni, F Sicard, F Martins, B Bournet, L Buscail, ... PloS one 10 (6), e0130996, 2015 | 124 | 2015 |
| CRISPR/Cas9: transcending the reality of genome editing S Chira, D Gulei, A Hajitou, AA Zimta, P Cordelier, I Berindan-Neagoe Molecular Therapy-Nucleic Acids 7, 211-222, 2017 | 120 | 2017 |
| First-in-man phase 1 clinical trial of gene therapy for advanced pancreatic cancer: safety, biodistribution, and preliminary clinical findings L Buscail, B Bournet, F Vernejoul, G Cambois, H Lulka, N Hanoun, ... Molecular Therapy 23 (4), 779-789, 2015 | 118 | 2015 |
